Literature DB >> 15467386

Stem cells and muscle diseases.

Vincenzo Sorrentino1.   

Abstract

In the past recent years, basic science work and initial clinical trials have provided starting evidence that stem cells are of potential value for treatment of certain human diseases, where they could help to regenerate tissues which are defective because of either genetic or acquired diseases. This area represents an emerging field of biomedicine based on a series of new discoveries in the field of stem cell biology and developmental biology that have made possible to isolate and expand stem cells from many human tissues. Additional evidence has also revealed the role of tissue environment that, by releasing a complex mixture of cytokines and growth factors, can influence the recruitment and functional integration of stem cells into specific organs. However, there is an urgent need for more advancement in basic biology of stem cells and related topics, which will be instrumental for the implementation of stem cell-based therapy at the clinical level, as treatment accessibility will depend on the acquisition of sufficient knowledge to develop adequate technologies to produce sufficient cell numbers and to drive their differentiating potentials.

Entities:  

Mesh:

Year:  2004        PMID: 15467386     DOI: 10.1023/b:jure.0000038366.50288.fb

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  58 in total

1.  Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation.

Authors:  Atsushi Asakura; Michael A Rudnicki
Journal:  Exp Hematol       Date:  2002-11       Impact factor: 3.084

2.  Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates.

Authors:  Fernando D Camargo; Rahshaana Green; Yassemi Capetanaki; Kathyjo A Jackson; Margaret A Goodell; Yassemi Capetenaki
Journal:  Nat Med       Date:  2003-11-16       Impact factor: 53.440

3.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

4.  Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study.

Authors:  R G Miller; K R Sharma; G K Pavlath; E Gussoni; M Mynhier; A M Lanctot; C M Greco; L Steinman; H M Blau
Journal:  Muscle Nerve       Date:  1997-04       Impact factor: 3.217

5.  Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution.

Authors:  Alain Bel; Emmanuel Messas; Onnik Agbulut; Patrice Richard; Jane-Lyse Samuel; Patrick Bruneval; Albert A Hagège; Philippe Menasché
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

Review 6.  Stem cells of the skin epithelium.

Authors:  Laura Alonso; Elaine Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-11       Impact factor: 11.205

Review 7.  Skeletal muscle satellite cell transplantation.

Authors:  Philippe Menasché
Journal:  Cardiovasc Res       Date:  2003-05-01       Impact factor: 10.787

8.  Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling.

Authors:  Alexandra Aicher; Winfried Brenner; Maaz Zuhayra; Cornel Badorff; Schirin Massoudi; Birgit Assmus; Thomas Eckey; Eberhard Henze; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circulation       Date:  2003-04-14       Impact factor: 29.690

9.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962

Review 10.  Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues.

Authors:  Giulio Cossu; Paolo Bianco
Journal:  Curr Opin Genet Dev       Date:  2003-10       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.